六味地黄方通过上调肠道雌激素受体改善绝经后ApoE-/-小鼠脂代谢异常研究
Liuwei Dihuang Formula Alleviates Abnormal Lipid Metabolism by Up-Regulating Intestinal Estrogen Receptors in Postmenopausal ApoE-/- Mice
-
摘要: 目的 应用双侧卵巢去势的ApoE-/-小鼠建立绝经后脂代谢异常模型，探究六味地黄方(LW)能否通过调节肠道雌激素受体改善绝经后脂代谢异常。方法 正常饮食的C57/B6小鼠为对照组(n=6)，高脂饮食并接受假手术的ApoE-/-小鼠为假手术对照组(n=6)，高脂饮食并接受双侧卵巢去势的的ApoE-/-小鼠为模型组(n=6)，模型小鼠接受4.5 g/kg (n=6)或9.0 g/kg (n=6)的六味地黄方治疗90 d。生化法检测小鼠血清中总胆固醇（TC）、甘油三酸酯（TG）、低密度脂蛋白（LDL-C）及高密度脂蛋白（HDL-C）水平，HE染色检测小鼠肝脏脂质损伤，油红染色检测小鼠肝脏脂质堆积，免疫荧光染色检测小鼠空肠雌激素受体α（ERα）、雌激素受体β（ERβ）、ABCG5、ABCG8、PI3K p110β及p-AKT的表达水平，免疫化学染色检测小鼠空肠NPC1L1的表达水平，Western blot法检测小鼠空肠NPC1L1、ABCG5及ABCG8的表达水平。结果 六味地黄方可降低模型小鼠血清TC、TG及LDL-C水平，升高HDL-C水平（P<0.05~0.01）；同时，六味地黄方可显著降低模型小鼠的肝脏脂质损伤和脂肪堆积（P<0.05~0.01）。六味地黄方显著增加模型小鼠空肠内降低的ERα和ERβ水平（P<0.05~0.01）。六味地黄方显著降低模型小鼠空肠中NPC1L1的表达水平（P<0.05），并上调ABCG5和ABCG8的表达水平（P<0.01）。六味地黄方显著增加模型小鼠空肠内PI3K p110β及p-AKT的表达水平（P<0.05~0.01）。结论 六味地黄方可以显著改善绝经后ApoE-/-小鼠脂代谢异常，其机制与六味地黄方调节肠道胆固醇的吸收和外排有关。上调肠道雌激素受体表达和肠道PI3K/AKT信号可能是六味地黄方调节肠道胆固醇吸收和外排的机制。Abstract: OBJECTIVE Establish a model of postmenopausal abnormal lipid metabolism in ApoE-/- mice by bilateral ovariectomy， and to explore whether Liuwei Dihuang formula (LW) can alleviate postmenopausal abnormal lipid metabolism by regulating intestinal estrogen receptors. METHODS C57/B6 mice with a normal diet were used as the control group (n=6)， ApoE-/- mice with a high-fat diet and receiving sham operations were used as the sham-operated control group (n=6)， ApoE-/- mice with a high-fat diet and receiving bilateral ovariectomy were used as the model group (n=6)， and the model mice received 4.5 g/kg (n=6) or 9.0 g/kg (n=6) LW for 90 days. Biochemical method was used to detect the levels of TC， TG， LDL-C and HDL-C in the serum of mice， HE staining was used to detect liver lipid damage in mice， oil red O staining was used to detect liver lipid accumulation in mice， immunofluorescence staining was used to detect mouse the expression levels of ERα， ERβ， ABCG5， ABCG8， PI3K p110β and p-AKT in the jejunum of mice， immunochemical staining was used to detect the expression level of NPC1L1 in the jejunum of mice. Western blot was used to detect the expression levels of NPC1L1， ABCG5 and ABCG8 in the jejunum of mice. RESULTS LW could reduce serum TC， TG and LDL-C levels， and increase HDL-C level in model mice（P<0.05， P<0.01）， moreover， LW could significantly reduce liver lipid damage and fat accumulation in model mice（P<0.05， P<0.01）. LW could increase the expression levels of ERα and ERβ in the jejunum of model mice（P<0.05， P<0.01）. LW significantly reduced the expression level of NPC1L1 in the jejunum of model mice（P<0.05）， and increased the expression levels of ABCG5 and ABCG8（P<0.01）. LW significantly increased the expression levels of PI3K p110β and p-AKT in the jejunum of model mice（P<0.05， P<0.01）. CONCLUSION LW can significantly improve the symptoms of abnormal lipid metabolism in postmenopausal ApoE-/- mice， and its mechanism may be related to the regulation of the intestinal cholesterol efflux and absorption. The up-regulated expression of intestinal estrogen receptor and PI3K/AKT signal in intestine may be the mechanism that how LW regulates intestinal cholesterol efflux and absorption.
-
Key words:
- postmenopausal /
- ApoE-/- mice /
- Liuwei Dihuang formula /
- lipid metabolism /
- estrogen receptor
-
[1] MUKA T， OLIVER-WILLIAMS C， KUNUTSOR S， et al. Association of age at onset of menopause and time since onset of menopause with cardiovascular outcomes， intermediate vascular traits， and all-cause mortality[J]. JAMA Cardiol， 2016， 1(7): 767. [2] AGRINIER N， COURNOT M， FERRIERES J. Dyslipidemia in women after 50: Age， menopause or both?[J]. Ann Cardiol Angeiol， 2009， 58(3): 159-164. [3] ANAGNOSTIS P， BITZER J， CANO A， et al. Menopause symptom management in women with dyslipidemias: An EMAS clinical guide[J]. Maturitas， 2020， 135: 82-88. [4] MOORE SC， MATTHEWS CE， SHU XO， et al. Endogenous estrogens， estrogen metabolites， and breast cancer risk in postmenopausal Chinese women[J]. J Natl Cancer Inst， 2016， 108(10): 103. [5] ADURTHI S， KUMAR MM， VINODKUMAR HS， et al. Oestrogen Receptor-α binds the FOXP3 promoter and modulates regulatory T-cell function in human cervical cancer[J]. Sci Rep， 2017， 7(1): 17289. [6] SAHA T， MAKAR S， SWETHA R， et al. Estrogen signaling: An emanating therapeutic target for breast cancer treatment[J]. Eur J Med Chem， 2019， 177: 116-143. [7] MEHTAJAYA M， CHESTERREBECCA C， KLINGJULIANA M. The timing hypothesis: Hormone therapy for treating symptomatic women during menopause and its relationship to cardiovascular disease[J]. J Womens Heal， 2019， 28(5): 705-711. [8] LECOMTE S， DEMAY F， FERRIERE F， et al. Phytochemicalstargeting estrogen receptors: Beneficial rather than adverse effects?[J]. Int J Mol Sci， 2017， 18(7): 1381. [9] 孔雪云， 张亚云， 吴祥， 等. 六味地黄丸对去卵巢ApoE-/-AS小鼠动脉粥样硬化的作用及机制研究[J]. 南京中医药大学学报， 2018， 34(4): 364-370. [10] CHEN Q， ZHANG YH， MENG QH， et al. Liuwei Dihuang prevents postmenopausal atherosclerosis and endothelial cell apoptosis via inhibiting DNMT1-medicated ERα methylation[J]. J Ethnopharmacol， 2020， 252: 112531. [11] ZHANG Y， QIAN X， SUN X， et al. Liuwei Dihuang， a traditional Chinese medicinal formula， inhibits proliferation and migration of vascular smooth muscle cells via modulation of estrogen receptors[J]. Int J Mol Med， 2018， 42(1): 31-40. [12] MENG Q， YU X， CHEN Q， et al. Liuwei Dihuang soft capsules inhibits the phenotypic conversion of VSMC to prevent the menopausal atherosclerosis by up-regulating the expression of myocardin[J]. J Ethnopharmacol， 2020， 246: 112207. [13] JING Y， CAI D， CHEN Q， et al. Liuwei Dihuang soft capsules attenuates endothelial cell apoptosis to prevent atherosclerosis through GPR30-mediated regulation in ovariectomized ApoE-deficient mice[J]. J Ethnopharmacol， 2017， 208: 185-198.〖HT5K〗〖JY〗（下转674页）〖HT〗〖FL)〗〖LM〗〖MM(L〗〖HT5”SS〗〖SX(B〗〖ZZ(S〗南京中医药大学学报2020年9月第36卷第5期〖〗〖WT6"BX〗J Nanjing Univ Tradit Chin Med Vol.36 No.5 Sep. 2020 〖ZZ)〗〖SX)〗〖MM)〗〖HT〗〖WT〗〖MD(1〗〖HT5SS〗 〖JY。〗〖MD)〗〖BT(1〗〖MZ(1H〗甘麦大枣汤联合氟西汀通过调控肠道菌群改善慢性应激小鼠抑郁症状的研究〖MZ)〗〖BT)〗〖ZW(〗〖HT〗〖JY〗〖FK(W3*2。46ZQ〗〖HT6H〗收稿日期： 2020-08-11 [14] PARK YM, ERICKSON C, BESSESEN D, et al. Age-and menopause-related differences in subcutaneous adipose tissue estrogen receptor mRNA expression[J]. Steroids, 2017, 121: 17-21. [15] PAKDEL F. Molecular pathways of estrogen receptor action[J]. Int J Mol Sci, 2018, 19(9): 2591. [16] ROTHENBERGER NJ, SOMASUNDARAM A, STABILE LP. The role of the estrogen pathway in the tumor microenvironment[J]. Int J Mol Sci, 2018, 19(2): 611. [17] TRENTI A, TEDESCO S, BOSCARO C, et al. Estrogen, angiogenesis, immunity and cell metabolism: Solving the puzzle[J]. Int J Mol Sci, 2018, 19(3): 859. [18] WNUK A, KAJTA M. Steroid andxenobiotic receptor signalling in apoptosis and autophagy of the nervous system[J]. Int J Mol Sci, 2017, 18(11): 2394. [19] DUAN LP, WANG HH, OHASHI A, et al. Role of intestinal sterol transporters Abcg5, Abcg8, and Npc1l1 in cholesterol absorption in mice: gender and age effects[J]. Am J Physiol Gastrointest Liver Physiol, 2006, 290(2): G269-G276. [20] WANG J, MITSCHE MA, LUTJOHANN D, et al. Relative roles of ABCG5/ABCG8 in liver and intestine[J]. J Lipid Res, 2015, 56(2): 319-330. [21] CHESKIS BJ, GREGER J, COOCH N, et al. MNAR plays an important role in ERa activation of Src/MAPK and PI3K/Akt signaling pathways[J]. Steroids, 2008, 73(9/10): 901-905. [22] LIC , LI Y, HE L, et al. PI3K/AKT signaling regulates bioenergetics in immortalized hepatocytes[J]. Free Radic Biol Med, 2013, 60: 29-40. [23] ZHOU W, ROWITZ BM, DAILEY MJ. Insulin/IGF-1 enhances intestinal epithelial crypt proliferation through PI3K/Akt, and not ERK signaling in obese humans[J]. Exp Biol Med, 2018, 243(11): 911-916. [24] XING SS, YANG XY, ZHENG T, et al. Salidroside improves endothelial function and alleviates atherosclerosis by activating a mitochondria-related AMPK/PI3K/Akt/ENOS pathway[J]. Vascul Pharmacol, 2015, 72: 141-152. -
点击查看大图
计量
- 文章访问数: 428
- HTML全文浏览量: 5
- PDF下载量: 305
- 被引次数: 0
下载:
